Home › Immuno-Oncology Promises Continued Wealth and Health: LifeTech Capital's Stephen Dunn
 

Keywords :   


Immuno-Oncology Promises Continued Wealth and Health: LifeTech Capital's Stephen Dunn

2015-02-20 23:54:20| Logistics - Topix.net

February 20, 2015 Immuno-oncology -- disabling cancer's defenses so that a patient's own immune system can seek it out and destroy it--took center stage in the drug development world in 2014. Stephen Dunn of LifeTech Capital believes that preeminence will continue in 2015, bolstered by new drug approvals, new targets and new combination immunotherapies that increase potency.

Tags: health continued stephen wealth

Category:Transportation and Logistics

Latest from this category

All news
26.06Atlantic Tropical Weather Outlook
26.06Eastern North Pacific Tropical Weather Outlook
26.06Eastern North Pacific Tropical Weather Outlook
26.06Atlantic Tropical Weather Outlook
26.06Eastern North Pacific Tropical Weather Outlook
26.06Atlantic Tropical Weather Outlook
25.06Atlantic Tropical Weather Outlook
25.06Eastern North Pacific Tropical Weather Outlook
Transportation and Logistics »
26.06Rockline Industries Wins WOW Innovation Award
26.06IMS Technologies Expands Calcinate Production Site
26.06Horizon expert 'gave evidence based on informal chats'
26.06Automotive Color by BASF Recognized with Renowned Red Dot Award
26.06Beckers Commits to Widespread Science Based Targets
26.06PPG to Announce Second-quarter 2024 Results July 18
26.06Fresh Coat for First Responders: New Hampshire Fire Station Gets a Makeover by California Paints
26.06Michigan Sets Record Recycling Rate in 2023, Recycles Nearly 70,000 Tons of Materials
More »